Evaluation of the efficacy, safety, and side effects of secukinumab in patients with moderate-to-severe psoriasis: real-world data from a retrospective multicenter study-Reference-Cited by-同舟云学术

Evaluation of the efficacy, safety, and side effects of secukinumab in patients with moderate-to-severe psoriasis: real-world data from a retrospective multicenter study

Published:2022-09 Issue:5 Volume:97 Page:566-574
ISSN:0365-0596
Container-title:Anais Brasileiros de Dermatologia
language:en
Short-container-title:Anais Brasileiros de Dermatologia

Author:

Oguz Topal Ilteris^ORCID,Baysak Sevim^ORCID,Altunay İlknur Kıvanç^ORCID,Kara Polat Asude^ORCID,Arıkan Eylem Emel^ORCID,Özkur Ezgi^ORCID,Aytekin Sema^ORCID,Dogan Bilal^ORCID,Özkök Akbulut Tuğba^ORCID,Topaloğlu Demir Filiz^ORCID,Karadağ Ayşe Serap^ORCID

Publisher

Elsevier BV

Subject

Dermatology

Reference35 articles.

1. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction;Stern;J Investig Dermatol Symp Proc.,2004

2. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics;Menter;J Am Acad Dermatol.,2008

3. Psoriasis: epidemiology;Gudjonsson;Clin Dermatol.,2007

4. Evalution of Clinical and Sociodemograpic Features of Patients with Psoriasis in the Konya Region;Aykol;Turk J Dermatol.,2011

5. The Evaluation of the Sociodemografic and Clinical Features of Patients with Psoriasis;Turan;Turk J Dermatol.,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of secukinumab in patients with psoriasis and psoriatic arthritis in a Saudi real-world setting;Advances in Rheumatology;2024-04-29

2. The immunological understanding on germinal center B cells in psoriasis;Journal of Cellular Physiology;2024-04-05

3. Immunological Processes in the Orbit and Indications for Current and Potential Drug Targets;Journal of Clinical Medicine;2023-12-22

4. Long-Term Efficacy, Safety, and Drug Survival of Guselkumab in Patients with Psoriasis: Real-World Data from the Czech Republic BIOREP Registry;Dermatology and Therapy;2023-02-01